COMPOSITIONS ET METHODES POUR LE TRAITEMENT DU CANCER AVEC UNE IMMUNOTHERAPIE ANTI-ROR1

• 收藏
• 分享

专利权人:

THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;LENTIGEN TECHNOLOGY, INC.

发明人:

DIMITROV, DIMITER S.,ZHU, ZHONGYU,ORENTAS, RIMAS J.,SCHNEIDER, DINA,DROPULIC, BORO

申请号：

CA3081719

公开号：

CA3081719A1

申请日:

2018.11.02

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

Chimeric antigen receptors containing ROR1 antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the chimeric antigen receptors are also disclosed. Methods of treating or preventing cancer in a subject, and methods of making chimeric antigen receptor T cells are also disclosed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/